The prevalence of Helicobacter pylori infection and the pattern of gastritis in Barrett's esophagus

Digestive Diseases

Volumn 19, Issue 2, 2001, Pages 164-169

  Peitz, Ulrich ^a   Hackelsberger, Andreas ^a   Günther, Thomas ^a   Clara, Lucia ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Barrett's esophagus; Gastritis parameters; H. pylori

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHRONICITY; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH ANTRUM;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 0034853203     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050672     Document Type: Article

References (30)

1. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
2. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
3. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
4. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia
5. Early detection of neoplasia of the esophagus and gastroesophageal junction
6. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data
7. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology
8. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?
9. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: Prevalences and associations with endoscopic erosive oesophagitis and gastritis
10. Gastric carcinoma risk index in patients infected with Helicobacter pylori
11. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis
12. Do we know the cause of reflux disease?
13. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany
14. Classification and grading of gastritis: The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
15. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: A case-control study
16. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the East
17. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the Cleveland Clinic Barrett's Esophagus Registry
18. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole
19. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease
20. H. pylori corpus gastritis - Relation to acid output
21. Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings
22. Helicobacter pylori infection and chronic gastric acid hyposecretion
23. Corpus gastritis is protective against reflux oesophagitis
24. The sero-prevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
25. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus
26. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis
27. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia
28. Atrophy and atrophic gastritis: One step beyond the Sydney system
29. Definition of histopathologic changes in gastroesophageal reflux disease
30. Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia